Stockreport

ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]

ALX Oncology Holdings Inc.  (ALXO) 
PDF immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today reported financial results for the fourth quarter and full year ended D [Read more]